ginsenoside rh2 has been researched along with Carcinoma, Lewis Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, LP; Chan, KM; Chan, RW; Dong, H; Guo, J; Guo, Y; Hsiao, WW; Jiang, ZH; Kam, RK; Kong, AN; Law, BY; Leung, EL; Liang, X; Liu, L; Wang, J; Wang, R; Wong, VK; Yen, FG; Yu, Z; Zhang, W; Zhou, H | 1 |
| Amosova, EN; Atopkina, LN; Kozlovskaia, EP; Krylova, SG; Lopatina, KA; Popov, AM; Razina, TG; Zueva, EP | 1 |
| Li, G; Liu, K; Wang, Z; Zheng, Q; Zheng, R | 1 |
3 other study(ies) available for ginsenoside rh2 and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.
Topics: Animals; Apoptosis; Azoxymethane; Carcinoma, Lewis Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dextran Sulfate; Drugs, Chinese Herbal; Energy Metabolism; Ginsenosides; Humans; Immunoblotting; Mice, Inbred C57BL; Mitochondrial Proteins; Molecular Structure; Neoplasms; Proteomics; S Phase Cell Cycle Checkpoints | 2016 |
[Effect of ginsenoside Rh2 on the development of transferred tumors and chemotherapy efficiency].
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cytostatic Agents; Drug Screening Assays, Antitumor; Female; Ginsenosides; Melanoma; Mice | 2010 |
Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cyclophosphamide; DNA Damage; Drugs, Chinese Herbal; Female; Ginsenosides; Immunosuppressive Agents; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micronuclei, Chromosome-Defective; Panax; Tumor Burden; Xenograft Model Antitumor Assays | 2006 |